Blockchain in Genomics Market Overview:

Blockchain technology has garnered a lot of reception in recent years owing to the advent of cryptocurrency and the other tech-oriented sectors initiating to implement this new yet potent technology. Cryptocurrencies like Bitcoin and Ethereum have provided the market an alternative to conventional monetary systems which has the potential to create a parallel economy across the world considering how widespread the internet services are global. Furthermore, the introduction of federated blockchain can be influential in changing the face of sectors like supply chain management, organizational records security, etc. With many tech giants inculcating the Blockchain as a Service (BaaS) feature shall boost the implementation of blockchain technology over the next few years.

The evaluation of the Blockchain in Genomics Market is performed based on factors, like for instance, the business expansion policies of key players, competitive analysis of the progress of new entrants and emerging players, the revenue, financial, and opportunity analysis of market players. The Blockchain in Genomics Market is also analyzed based on the regional segmentation, product type or technique, end-user spectrum, etc. This research will be conducted with the implementation of the latest market research methodologies which shall help organizations comprehend the overall market scenario and strategize accordingly.

Major players included in the Blockchain in Genomics Market:

  • DNAtix
  • Shivom
  • Zenome
  • Luna DNA
  • EncrypGen
  • Nebula Genomics
  • GSK
  • Pfizer
  • Genobank.io
  • Merck
  • Genomes.io
  • WuXi Nextcode Genomics
  • Murrieta Genomics
  • Gene Blockchain
  • Longenesis
  • SimplyVital Health
  • Neogen
  • Ripe Technology

(Note: The list of the major players will be updated with the latest market scenario and trends)

Blockchain in Genomics Market Segmentation:
By Type

  • Private
  • Public
  • Federated

By Application

  • Clinical Trials
  • IP Management
  • Drug Discovery
  • Data Storage and Security

By Models

  • Token-Economy
  • Services
  • Development Platforms
  • Blockchain-Based Software Products

By Target

  • B2C
  • B2B
  • C2C

By End User

  • Pharmaceutical Companies
  • Research Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Blockchain in Genomics Market Competitive Analysis:

  • Tier-1 Players
  • Tier-2 Players
  • Emerging Players
  • New Entrants

Future Market Analytics Focus Points:

  • SWOT Analysis
  • Key Market Trends
  • Key Data -Points Affecting Market Growth
  • Revenue and Forecast Analysis
  • Growth Opportunities For New Entrants and Emerging Players
  • Key Player and Market Growth Matrix

Objectives of the Study:

  • To provide a comprehensive analysis on the Blockchain in Genomics Market by type, by application, by models, by target, by end user and by region
  • To cater extensive insights on factors influencing the market growth (drivers, restraints, industry-specific restraints, business expansion opportunities)
  • To anticipate and analyse the market size expansion in key regions- North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- strategic alliances and mergers, technological advancements and product launches, revenue and financial analysis of key market players

 
In case of any requirements or changes to the current table of content please contact us at:enquiry@futuremarketanalytics.com

Description

1. Market Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Market Scope
         1.3.1 Years Considered for the Study
         1.3.2 Market Covered
    1.4. Currency
    1.5. Limitations
    1.6. Stakeholders

2. Research Methodology
    2.1. Research Data
         2.1.1. Secondary Data
                2.1.1.1. Key Data from Secondary Sources
         2.1.2. Primary Data
                2.1.2.1. Key Data from Primary Sources
    2.2. Market Size Estimation
    2.3. Market Breakdown and Data Triangulation
    2.4. Assumptions for the Study

3. Executive Summary
    3.1. Market Outlook
    3.2. Segment Outlook
    3.3. Competitive Insights

4. Market Variables, Trends & Scope
    4.1. Market Lineage Outlook
    4.2. Penetration and Growth Prospect Mapping
    4.3. Industry Value Chain Analysis
    4.4. Cost Analysis Breakdown
    4.5. Technology Overview
    4.6. Regulatory Framework on Country Level
         4.6.1. Reimbursement Framework
         4.6.2. Standards and Compliances

5. Market Overview
    5.1. Market Dynamics
         5.1.1. Market Driver Analysis
         5.1.2. Market Restraint Analysis
         5.1.3. Industry Challenges

6. Market Analysis Tools
    6.1. Industry Analysis – Porter’s
         6.1.1. Supplier Power
         6.1.2. Buyer Power
         6.1.3. Substitution Threat
         6.1.4. Threat from new entrants
         6.1.5. Competitive Rivalry
    6.2. Pestel Analysis
         6.2.1. Political Landscape
         6.2.2. Environmental Landscape
         6.2.3. Social landscape
         6.2.4. Technology landscape
         6.2.5. Legal Landscape

7. Blockchain In Genomics Market, By Type Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
    7.1. Private
    7.2. Public
    7.3. Federated

8. Blockchain In Genomics Market, By Application Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
    8.1. Clinical Trials
    8.2. IP Management
    8.3. Drug Discovery
    8.4. Data Storage and Security

9. Blockchain In Genomics Market, By Models Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
    9.1. Token-Economy
    9.2. Services
    9.3. Development Platforms

    9.4. Blockchain-Based Software Products

10. Blockchain In Genomics Market, By Target Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
    10.1. B2C
    10.2. B2B
    10.3. C2C

11. Blockchain In Genomics Market, By End User Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
    11.1. Pharmaceutical Companies
    11.2. Research Institutes

12. North America Market Analysis 2016-2020 and Forecast 2021–2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         12.2.1. U.S.
         12.2.2. Canada
         12.2.3. Mexico
         12.2.4. Rest of North America
    12.3. Market Size (USD Mn) Forecast for North America 2021-2028

13. Latin America Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    13.1. Introduction
    13.2. Regional Market Trends
    13.3. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         13.3.1. Brazil
         13.3.2. Venezuela
         13.3.3. Argentina
         13.3.4. Rest of Latin America
    13.4 Market Size (USD Mn) Forecast for Latin America 2021-2028

14. Europe Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         14.2.1. Germany
         14.2.2. U.K
         14.2.3. France
         14.2.4. Italy
         14.2.5. Switzerland
         14.2.6. Spain
         14.2.7. Russia
         14.2.8. Poland
         14.2.9. Rest of Europe
    14.3. Market Size (USD Mn) Forecast for Europe 2021-2028

15. Asia Pacific Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    15.1. Introduction
    15.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         15.2.1. Japan
         15.2.2. China
         15.2.3. Singapore
         15.2.4. Korea
         15.2.5. India
         15.2.6. Australia and New Zealand
         15.2.7. ASEAN
         15.2.8. Rest of Asia Pacific
    15.3. Market Size (USD Mn) Forecast for Asia Pacific 2021-2028

16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    16.1. Introduction
    16.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         16.2.1. UAE
         16.2.2. South Africa
         16.2.3. Egypt
         16.2.4. Saudi Arabia
         16.2.5. Rest of MEA
    16.3. Market Size (USD Mn) Forecast for MEA 2021-2028

17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    17.1. DNAtix
         17.1.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.1.2. Product Portfolio
         17.1.3. SWOT Analysis
         17.1.4. Financial Overview
         17.1.5. Strategic Overview
    17.2. Shivom
         17.2.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.2.2. Product Portfolio
         17.2.3. SWOT Analysis
         17.2.4. Financial Overview
         17.2.5. Strategic Overview
    17.3. Zenome
         17.3.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.3.2. Product Portfolio
         17.3.3. SWOT Analysis
         17.3.4. Financial Overview
         17.3.5. Strategic Overview
    17.4. Luna DNA
         17.4.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.4.2. Product Portfolio
         17.4.3. SWOT Analysis
         17.4.4. Financial Overview
         17.4.5. Strategic Overview
    17.5. EncrypGen
         17.5.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.5.2. Product Portfolio
         17.5.3. SWOT Analysis
         17.5.4. Financial Overview
         17.5.5. Strategic Overview
    17.6. Nebula Genomics
         17.6.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.6.2. Product Portfolio
         17.6.3. SWOT Analysis
         17.6.4. Financial Overview
         17.6.5. Strategic Overview
    17.7. GSK
         17.7.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.7.2. Product Portfolio
         17.7.3. SWOT Analysis
         17.7.4. Financial Overview
         17.7.5. Strategic Overview
    17.8. Pfizer
         17.8.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.8.2. Product Portfolio
         17.8.3. SWOT Analysis
         17.8.4. Financial Overview
         17.8.5. Strategic Overview
    17.9. Genobank.io
         17.9.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.9.2. Product Portfolio
         17.9.3. SWOT Analysis
         17.9.4. Financial Overview
         17.9.5. Strategic Overview
    17.10. Merck
         17.10.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.10.2. Product Portfolio
         17.10.3. SWOT Analysis
         17.10.4. Financial Overview
         17.10.5. Strategic Overview
    17.11. Genomes.io
         17.11.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.11.2. Product Portfolio
         17.11.3. SWOT Analysis
         17.11.4. Financial Overview
         17.11.5. Strategic Overview
    17.12. WuXi Nextcode Genomics
         17.12.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.12.2. Product Portfolio
         17.12.3. SWOT Analysis
         17.12.4. Financial Overview
         17.12.5. Strategic Overview
    17.13. Murrieta Genomics
         17.13.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.13.2. Product Portfolio
         17.13.3. SWOT Analysis
         17.13.4. Financial Overview
         17.13.5. Strategic Overview
    17.14. Gene Blockchain
         17.14.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.14.2. Product Portfolio
         17.14.3. SWOT Analysis
         17.14.4. Financial Overview
         17.14.5. Strategic Overview
    17.15. Longenesis
         17.15.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.15.2. Product Portfolio
         17.15.3. SWOT Analysis
         17.15.4. Financial Overview
         17.15.5. Strategic Overview
    17.16. SimplyVital Health
         17.16.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.16.2. Product Portfolio
         17.16.3. SWOT Analysis
         17.16.4. Financial Overview
         17.16.5. Strategic Overview
    17.17. Neogen
         17.17.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.17.2. Product Portfolio
         17.17.3. SWOT Analysis
         17.17.4. Financial Overview
         17.17.5. Strategic Overview
    17.18. Ripe Technology
         17.18.1. Company Overview (HQ, Business Segments, Employee Strength)
         17.18.2. Product Portfolio
         17.18.3. SWOT Analysis
         17.18.4. Financial Overview
         17.18.5. Strategic Overview

18. Impact of COVID-19
    18.1. Positive influence on the industry
    18.2. The financial disruption of the sector
    18.3. Impact of COVID-19 on emerging companies
    18.4. Significant mandates in the industry regulations initiated by administrations
    18.5. The overall economic slowdown of the developing and developed nations

19. Competitive Intelligence and Competitive Matrix
    19.1. Competitive Intelligence
    19.2. Competitive Matrix

20. Major Deals and Strategic Alliances Analysis
    20.1. Joint ventures
    20.2. Mergers and acquisitions
    20.3. Licensing and partnerships
    20.4. Technology Collaborations
    20.5. Strategic Divestments
    20.6. Market Entry Strategies

21. Relevant Case Studies and Latest News Updates

22. Key Market Takeaway Points from the Market Analysts at Future Market Analytics